Exploration) Study aimed to understand factors associated with the initiation and maintenance of sustained heroin cessation from the perspective of users themselves and specifically set out to document the correlates of natural recovery. The CHANGE Study was a case-control study conducted in New York City from 2009 to 2011. Cases were former heroin users, abstinent for 1-5 years in the past 5 years. Controls used heroin at least weekly during the past 5 years and were (1) continuous heroin users without a quit attempt of ≥2 weeks' duration or (2) relapsed heroin users who were currently using and had a quit attempt of ≥2 weeks' duration during the past 5 years. Recruitment and data collection methods are described along with limitations and a brief description of the study sample. In contrast to many studies of drug use and cessation, the CHANGE Study was designed to model success (i.e., initiation and maintenance of heroin cessation) and not failure.
The cessation of drug use (also called recovery, remission, and sobriety) is the ultimate goal for many interventions. Recovery has been described as a process that takes years before cessation is complete, with relapses often occurring along the way. 7, 8 Cyclical patterns of use, non-use, and treatment are common. 2, [7] [8] [9] [10] [11] [12] These patterns may be related to a variety of factors including opportunity and availability of the drug, detention/ incarceration, and treatment (by type, duration, quality), among other factors.
With some exceptions, 11, [13] [14] [15] studies of heroin cessation have generally been conducted within treatment samples. 7, 8, [16] [17] [18] [19] [20] Indeed, much of the extant literature about heroin cessation has focused on the role of treatment. There are three main treatment modalities available for heroin abuse: pharmacotherapy (e.g., methadone, buprenorphine, etc.), behavioral therapy, and 12-step programs [e.g., Narcotics Anonymous [NA] ). These modalities have varying degrees of success. Many studies have been conducted to evaluate different treatment modalities and pharmacotherapies and thus are mostly concerned with drug-free outcomes. However, interim milestones, such as cessation of heroin with continuation of other drug use, may be important in understanding the process of cessation.
The large body of work that has focused on the role of treatment in heroin cessation has, to an extent, obscured the possibility of Bnatural recovery^(i.e., cessation without treatment). It has been postulated by some that heroin cessation could only occur in the context of substance use treatment. Another hypothesis is the prospect of natural or Bspontaneous^recovery. [21] [22] [23] [24] [25] [26] Natural recovery is a change in behavior by an individual without the aid of formal interventions. 21 The concept of natural recovery has been considered taboo. 27 Researchers who have examined it often contend that natural recovery is not an uncommon phenomenon, but previous research efforts appear to have been biased by (1) the large body of research on treatment outcomes [28] [29] [30] where the sampling was in treatment settings which by definition takes individuals who have not recovered spontaneously and (2) the difficulty in finding people who have stopped using heroin on their own. 31 The CHANGE (Cessation of Heroin: A Neighborhood Grounded Exploration) Study aimed to understand factors associated with the initiation and maintenance of sustained heroin cessation from the perspective of users themselves and specifically set out to document the correlates of natural recovery. Here, we describe the methods for the CHANGE Study and provide a brief description of the study sample.
METHODS/DESIGN Study Design and Setting
The CHANGE Study was a case-control study conducted in New York City (NYC) from 2009 to 2011. The purpose of the study was to identify factors associated with initiating and sustaining heroin cessation. Participants were recruited in 38 economically disadvantaged neighborhoods throughout four boroughs of NYC (Bronx, Brooklyn, Manhattan, and Queens). The identification and selection of neighborhoods have been previously described. 32 
Recruitment
Participants were recruited using a three-pronged approach: street intercept, walkin, and referral from another participant. For street intercept recruitment, experienced outreach staff approached individuals in target neighborhoods.
Interested individuals were asked questions about their background and drug use. Those who reported lifetime heroin use were invited to make an appointment to undergo further eligibility screening at a research storefront or on a mobile vehicle stationed in a target neighborhood. For those who were hesitant or not immediately available, hand cards with study information were distributed and outreach staff encouraged individuals to call the toll-free study telephone number for more information and/or pass on hand cards to individuals who may have been interested in the study (and eligible). Interested individuals who approached us or Bwalked int o either the research storefront or mobile recruitment vehicle and inquired about the study were provided with study information, pre-screened, and offered an appointment to return. Lastly, an individual could have approached study staff after receiving a referral coupon from a friend who had already participated in the study. Participants were remunerated $5 for each friend who brought in a coupon and was found eligible.
Once at the storefront or mobile vehicle, pre-screened individuals underwent full eligibility screening with a 10-min survey that gathered detailed background and drug use information. Potential participants provided a urine sample for heroin, methadone, and cocaine testing with one-step test strips for opiates, methadone, and cocaine (Innovacon, Inc., China) to confirm self-reported drug use or abstinence. At the time of urine collection, participants were asked whether they had used opioids or cough/cold medicine in the last 3 days. They were also asked if they had eaten poppy seeds or drank tonic water in the last 3 days. These questions were used to identify possible false-positive urine tests among the former drug users. Written informed consent was required for eligibility screening, including the urine testing.
Eligibility Criteria
Common eligibility for study inclusion into the case and control groups included history of chronic heroin use (defined as ≥weekly use for ≥1 year); age ≥27 years; lived or spent at least half their time in a target NYC neighborhood; and written informed consent for the study, which included a questionnaire and blood (or oral samples) for HIV testing.
Case and Control Definitions
Cases were former heroin users who had reported being abstinent in the year prior to enrollment and up to 5 years continuously in the last 5 years. They also provided a negative opiate urine test or a positive opiate urine test with evidence for possible false-positive results or use of other opiates (N=322). There were two control groups: (1) continuous and (2) relapsed heroin users. Continuous heroin users reported using heroin at least weekly during the past 5 years and had either reported never trying to quit or reported never quitting for a minimum of 2 weeks (N=345). Relapsed heroin users reported being abstinent at least once for a period of 2 weeks or more during the past 5 years but had relapsed and were currently using heroin (N=509). The 2-week period of cessation for relapsers was chosen to take into account heroin pharmacology. The onset of heroin withdrawal generally occurs 8-12 h after the last dose, peaking after 48-72 h. 33 Many individuals try to stop using heroin but have difficulty dealing with withdrawal. By defining a cessation attempt as 2 or more weeks with no heroin use, we were controlling for withdrawal as a correlate of cessation relapse. To be eligible, both relapsed and continuous heroin users were required to provide a positive heroin urine test if they reported heroin use in the past 2 days.
Data Collection
Eligible participants underwent a second written informed consent and completed a structured interview that included questions about drug use, cessation attempts, motivations to quit, and tools and strategies utilized to quit heroin. At the conclusion of enrollment, all participants were given three referral coupons to give to three friends with whom they used drugs. Each participant received $30 and a roundtrip MetroCard for the local subways and buses. Those who returned to the storefront for HIV blood test results received $5 and a roundtrip MetroCard.
Measures
Measures were identified based on a close review of the extant literature. In addition, indepth interviews with 31 current and former heroin users describing predictors and processes that hinder or promote sustained heroin abstinence informed measure selection and development. 34 Descriptions of selected key measures follows.
Demographic and Socioeconomic Characteristics
Demographic variables included sex, race/ethnicity (i.e., Black, Hispanic, White, or Other), age, sexual identity (i.e., heterosexual or homosexual/gay/lesbian/bisexual), educational attainment, and marital status. Main income sources in the past 6 months included employment, public assistance, informal economy, income from someone else, and illegal activities. Employment was defined as having a full-or part-time job, owning a business, or having temporary work. Public assistance included income from government benefits including public assistance, welfare, and other state or federal benefits such as food stamps, disability, or unemployment. The informal economy category refers to money received from recycling cans, returning bottles for deposits, windshield wiping, or panhandling. Income from someone else refers to money from a parent, friend, relative, or spouse. The illegal activities category included theft, robbing, stealing, or conning, selling drugs, and sex for money. We asked about total legal (Bon the books^and before taxes) and total untaxed (Boff the books^) income in the past year. Because the income distribution was limited, we categorized the income variables as no income or ≤$5000, $5000-$10,000, and 9$10,000 per year. Table 1 summarizes the demographic and socioeconomic characteristics of the entire sample.
Drug Use Careers
We asked about lifetime and recent (past 3 months) use along with age of onset of use of a variety of drugs, drug combinations, and routes of administration. With respect to heroin use, we asked about sniffing or snorting heroin alone or in combination with cocaine, injecting heroin alone or combination with cocaine (i.e., speedball) or amphetamine, and smoking heroin alone or in combination with marijuana or crack. We also asked about other opiates including street methadone (i.e., not prescribed to the user from a program) and other narcotics. In addition to the heroin/heroin combination variables, we asked participants whether they had smoked cigarettes, smoked marijuana/hash, sniffed/snorted or injected cocaine, injected or smoked crack (including Bready rock^or freebase cocaine), or snorted, smoked, or injected methamphetamine. We also asked whether participants had used PCP, LSD, ecstasy, other hallucinogens (e.g., mushrooms, peyote, mescaline), or inhalants (e.g., sniffing glue, Blocker room,^poppers, nitrous oxide). For all relevant prescription drugs (i.e., tranquilizers, downers, or barbiturates; speed, amphetamines, or stimulants; and steroids), interviewers made sure to clarify we were interested in drugs that were not prescribed by a doctor. We also asked about lifetime and current drug of choice. Table 2 summarizes lifetime use of specific drugs, drug combinations, and routes of administration for the entire sample. 
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Heroin Cessation
Heroin cessation was the outcome of interest. Respondents were asked if they had ever had a cessation attempt ≥2 weeks. If they had, they were then asked about the date and duration of the first, most recent, and longest cessation attempts. Due to concerns of recall bias, inquiries focused on the first and most recent cessation attempts. We assessed internal and external motivations for cessation, tools and strategies used to quit, and strategies employed for sustained cessation. Because cessation is often a stressful endeavor, we asked respondents about possible negative feelings during their cessation attempts and whether they experienced craving for heroin or other drugs. If they reported having experienced drug cravings, we asked about their duration, intensity, and frequency of cravings. We also asked about the role of religion/spirituality in the cessation attempt, specifically assessing whether religion/spirituality had helped with cessation, whether the respondent became more religious/spiritual when trying to stop or when they stopped using heroin, and whether they converted to a religion to help them quit. Among those who had reported experiencing a relapse, we asked about reasons for their relapse(s).
Drug Treatment
Respondents were asked if they had ever been in drug treatment and if they were currently in treatment. For the first, most recent, and longest treatment experiences, we assessed date of entry, age at entry, heroin use frequency and quantity prior to entry, amount of money spent on heroin prior to entry, whether methadone was used, perception of helpfulness for heroin cessation, and duration of abstinence. Motivations for treatment entry were queried for the first and most recent cessation attempts. We asked about the use of pharmacotherapy including methadone, L-α-acetylmethadol (LAAM), buprenorphine, naltrexone, slow-release oral morphine, and clonidine for the first and most recent cessation attempts. For those using pharmacotherapy, we asked about treatment duration, initial and current dosage, respondents' perception of whether pharmacotherapy helped with heroin cessation, and intentions to stop using pharmacotherapy.
Treatment program components were assessed, such as whether counselors or sponsors, group sessions, family therapy, and/or urine testing was a part of the treatment program. We asked whether the treatment program offered additional services (e.g., medical care, mental health services, HIV testing), and Narcotics Anonymous (NA) participation was also assessed. For NA as well as each program component or additional service, we asked whether respondents thought it was helpful for initiating and sustaining cessation for the first and most recent cessation attempts. Treatment program satisfaction included items such as comfort with counselor(s) and program participants, convenience of location and hours, satisfaction with one-on-one sessions, and comfort with program rules. For those who had never been in treatment, we ascertained reasons for not seeking treatment.
Incarceration is a common experience for illicit drug users and has been shown to be associated with cessation as well as relapse. 2, [35] [36] [37] We ascertained whether participants had ever been incarcerated, and for those who had been to jail or prison, we asked about their most recent incarceration. We asked about services offered prior to release from the most recent incarceration such as appointments, referrals, or information for finding a health care provider, information for finding a mental health care provider, discharge planning, aftercare support, medication, assistance or information for applying for public assistance or Medicaid, and case management. We also asked about health services they received postincarceration and whether they have difficulty accessing health and social services.
DISCUSSION
The CHANGE Study sample is a highly impoverished group of former, continuous, and relapsed heroin users that is diverse with respect to sex, race/ethnicity, sexual orientation, and educational attainment. In addition to heroin, the vast majority of CHANGE participants had smoked cigarettes and used cocaine, marijuana, and crack in their lifetime. More than half (55 %) had injected heroin in their lifetime, and 36.5 % had injected speedballs (heroin and cocaine together). Methamphetamine use was rare, with only 13 % reporting any use.
The purpose of this case-control study is to characterize factors associated with initial and sustained cessation of heroin use among persons who report a history of chronic heroin use within economically disadvantaged, predominantly racial/ethnic minority neighborhoods in New York City (NYC). Groundbreaking studies in the 1960s, 1970s, and 1980s provided mostly descriptive data on the natural history of drug abuse with samples drawn from drug abuse treatment and the criminal justice system. 9, 12, 22, [38] [39] [40] [41] [42] [43] [44] [45] [46] Natural recovery is less well studied, 11, 13, 14, 31, 47 especially recently, and data are sparse on the factors associated with sustained heroin cessation, particularly among street-recruited samples. The CHANGE Study focused on cessation of heroin use specifically, as opposed to cessation of all drugs or cessation of drug injection for three primary reasons. First, there is ample evidence that the determinants of use of various drugs are different. [48] [49] [50] Therefore, a study attempting to assess determinants of multiple drug use patterns (e.g., cessation of heroin and cocaine) simultaneously would be likely to produce results that are difficult to interpret and less likely to suggest fruitful avenues for intervention. Second, in focusing on heroin use and cessation, the CHANGE Study was designed to consider the use of other drugs as potentially important correlates of heroin cessation. Although studies have demonstrated that poly-substance use is associated with a greater likelihood of morbidity and mortality than the use of one substance alone, 51, 52 in order to understand complex patterns of substance use, we first must systematically assess heroin use alone and recognize that the determinants of heroin use and cessation are likely quite different than those of other drugs. Third, a study that tried to rigorously assess the determinants of multiple-drug cessation would need a prohibitively large sample size to include all the relevant groups of interest (e.g., cessation of two drugs, cessation of drug A but not drug B, cessation of drug B but not drug A, cessation of neither).
There are several limitations to the CHANGE Study that must be acknowledged. The CHANGE Study was a case-control study, and therefore, any temporal associations that are observed are based upon self-report. As in any study of drug use cessation, the former heroin users (i.e., the cases) have the potential to become controls (i.e., relapsers). The CHANGE sample may not be representative of all former, continuous, and relapsed heroin users as the sample was highly impoverished, with at least 93 % living below the 2009 federal poverty threshold for a single individual-$10,956 per year 53 and the majority (89 %) were Black or Hispanic/Latino. A recent sample of individuals entering heroin treatment in 48 states was 79.5 % White; 54 similarly, 64.9 % of heroin admissions in the 2012 Treatment Episode Data Set (TEDS) were White. 55 However, this highly diverse sample is unique and facilitates examination of racial and ethnic differences in heroin cessation correlates.
In contrast to many studies of drug use and cessation, the CHANGE Study was designed to model success (i.e., initiation and maintenance of heroin cessation) and not failure. Future analyses of the CHANGE Study will identify factors associated with the initiation and maintenance of heroin cessation.
